News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
832
Sources here
24
Companies here
19
Search results Stored financial headlines

Active search

832 matching headlines

Ticker or company: IVAMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

20 Participants Dosed in Semaglutide Trial; Data Due in November

Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares

LivaNova PLC's Chief Innovation Officer, Ahmet Tezel, exercised 12,692 Stock Appreciation Rights (SARs) at a base price of $52.68 per share. Concurrently, 8,589 shares were withheld to cover the SARs base price, 1,428 shares for tax liability, and 2,675 shares were sold on the …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Activate Energy Acquisition Corp. Q2 2026: Net income $1.76M, EPS $0.06— 10-Q Summary

Activate Energy Acquisition Corp. reported a net income of $1.76 million for Q2 2026, primarily from interest income on its Trust Account, resulting in diluted EPS of $0.06. The company, a SPAC, is focused on identifying and completing a business combination, holding $234.6 million …

AEAQ main company
Sharemaestro market context Stored weekly price path 29 weeks +1.8% · Next-week setup negative 39.5% AEAQ stored weekly price path from 30 Jan 2026 to 14 Aug 2026

Does Clarivate’s Expanded Agentic AI Across Cortellis Reshape the Bull Case For Clarivate (CLVT)?

Clarivate Plc has expanded agentic AI capabilities across its Cortellis life sciences portfolio, aiming to integrate AI into drug discovery, safety assessment, and portfolio decision workflows. This move seeks to reduce manual effort and support faster, evidence-based decisions, reinforcing Clarivate's investment narrative around workflow …

CLVT main company
Sharemaestro market context Price below Trend Line 52 weeks -57.1% · Next-week setup negative 41.5% CLVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivakor and M2i Global Announce Strategic Collaboration to Advance U.S. Critical Minerals Supply Chain

Vivakor, Inc. and M2i Global, Inc. have entered into an Indication of Interest to explore a potential business combination. The collaboration aims to strengthen the U.S. critical minerals supply chain and advance domestic mineral independence. This strategic move could expand Vivakor's commodities marketing and …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

Abivax S.A. (ABVX) investors report 6.0% beneficial stake via Invus entities

Invus Public Equities, L.P. and affiliated entities, including Avicenna Life Sci Master Fund LP, have collectively reported a 6.0% beneficial ownership in Abivax S.A. (ABVX) as of June 30, 2026. This stake, comprising Ordinary Shares and American Depositary Shares, totals 4,825,759 shares attributed to …

ABVX main company
Sharemaestro market context Trend signal active 52 weeks +53.9% · Next-week setup positive 57.2% ABVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

M2i Global and Vivakor sign deal to explore merger to boost US critical minerals supply chain

M2i Global Inc and Vivakor Inc have signed a non-binding agreement to explore a merger. The proposed deal aims to combine M2i's critical minerals platform with Vivakor's commodities marketing and remediation businesses to create a larger US-focused platform. This merger is intended to strengthen …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

Vivakor and M2i Set 30-Day Window to Explore Critical Minerals Deal

Vivakor (Nasdaq: VIVK) and M2i Global (OTCQB: MTWO) have signed an Indication of Interest (IOI) to explore a potential business combination and strategic collaboration focused on advancing the U.S. critical minerals supply chain. The IOI outlines an initial 30-day period for negotiating valuation, transaction …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

EXCLUSIVE: Vivakor Targets Critical Minerals Expansion Through Potential M2i Acquisition

Vivakor Inc. (NASDAQ: VIVK) and M2i Global Inc. (OTCQB: MTWO) have signed a non-binding indication of interest to explore a potential business combination. This proposed merger aims to expand Vivakor's operations into critical minerals, support the U.S. critical minerals supply chain, and combine their …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

Is Clarivate (CLVT) Below Fair Value On Its Cortellis Agentic AI Expansion?

Clarivate (CLVT) has expanded its Cortellis portfolio with new agentic AI capabilities aimed at accelerating life sciences R&D, despite its stock experiencing a significant decline. The company's valuation narrative suggests it is undervalued at $2.50 per share compared to its current price of $1.91, …

CLVT main company
Sharemaestro market context Price below Trend Line 52 weeks -57.1% · Next-week setup negative 41.5% CLVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Clarivate : and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes

Clarivate and KYBORA have partnered to offer integrated, end-to-end transaction advisory services for bioph

CLVT main company
Sharemaestro market context Price below Trend Line 52 weeks -57.1% · Next-week setup negative 41.5% CLVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Roivant’s year-long trend leaves valuation stretch as the sharper issue near a 52-week high

ROIV closed at $36.34, just 1.8% below its 52-week high, with an active Trend Signal and positive biotech context offset by only moderate volume confirmation.

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record …

LIVN main company L2IV34 main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Roivant Sciences Ltd. (ROIV) Affects Rotational Strategy Timing

This article analyzes Roivant Sciences Ltd. (ROIV) through AI-generated trading strategies and multi-timeframe signal analysis. It highlights a near-term strong sentiment transitioning to a long-term positive bias, with an exceptional 28.3:1 risk-reward setup. The analysis provides specific entry, target, and stop-loss zones for various …

ROIV main company
Sharemaestro market context Trend signal active 52 weeks +203.7% · Next-week setup positive 59.1% ROIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova (LIVN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Briana Gotlin Chief Executive Officer and member of the Board of Directors - Vladimir Makatsaria Chief Innovation Officer - Ahmet Tezel Chief …

LIVN main company L2IV34 main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Three Innoviva therapies named finalists for Prix Galien award

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., announced that three of its infectious disease therapies—XACDURO, ZEVTERA, and NUZOLVENCE—have been named finalists for the 2026 Prix Galien USA Award in the Best Pharmaceutical Product category. This marks the third consecutive year an Innoviva product …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale

LivaNova PLC has reported a planned sale of 2,675 shares of common stock, stemming from the exercise of employee stock appreciation rights. The transaction, valued at $209,942.40, is scheduled for August 11, 2026, and will be executed through Merrill Lynch as a broker-assisted cashless …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivakor reports increased crude oil marketing activity By Investing.com

Vivakor Inc. (NASDAQ:VIVK) has reported increased activity in its physical crude oil marketing platform due to geopolitical uncertainties in the Middle East causing volatility in global crude oil markets. The company's Vivakor Supply & Trading, LLC unit is experiencing higher activity and aims to …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

Vivakor Sees Increased Activity as Oil Pricing Jumps Due to Continuing Middle East Conflict and Rising Uncertainty in Strait of Hormuz

Vivakor, Inc. (Nasdaq: VIVK) has reported increased activity in its Supply and Trading business, VST, driven by geopolitical instability in the Middle East and rising oil prices. The company attributes this growth to its strategic expansion, recurring contracted volumes, and expanding commercial relationships. Vivakor …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context